Research progress on the antitumor effects of harmine
Frontiers in Oncology · 25.03.2024 · 14
DOI: 10.3389/fonc.2024.1382142 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 25.03.2024. Verfasst von Yonghua Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of the Digestive System Tumors of Gansu Province, Department of Tumor Center, The Second Hospital & Clinical Medical School, Lanzhou U…. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Harmine is a naturally occurring β-carboline alkaloid originally isolated from Peganum harmala . As a major active component, harmine exhibits a broad spectrum of pharmacological properties, particularly remarkable antitumor effects. Recent mechanistic studies have shown that harmine can inhibit cancer cell proliferation and metastasis through epithelial-to-mesenchymal transition, cell cycle regulation, angiogenesis, and the induction of tumor cell apoptosis. Furthermore, harmine reduces drug resistance when used in combination with chemotherapeutic drugs. Despite its remarkable antitumor activity, the application of harmine is limited by its poor solubility and toxic side effects, particularly neurotoxicity. Novel harmine derivatives have demonstrated strong clinical application prospects, but further validation based on drug activity, acute toxicity, and other aspects is necessary. Here, we present a review of recent research on the action mechanism of harmine in cancer treatment and the development of its derivatives, providing new insights into its potential clinical applications and strategies for mitigating its toxicity while enhancing its efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of the Digestive System Tumors of Gansu Province, Department of Tumor Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
- The First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
- Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, China.
Zitieren
APA
Hu, Y., Yu, X., Yang, L., Xue, G., Wei, Q., Han, Z., & Chen, H. (2024). Research progress on the antitumor effects of harmine. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1382142
Vancouver
Hu Y, Yu X, Yang L, Xue G, Wei Q, Han Z, et al. Research progress on the antitumor effects of harmine. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1382142
BibTeX
@article{Hu2024,
author = {Hu, Yonghua and Yu, Xiaoli and Yang, Lei and Xue, Gaimei and Wei, Qinglin and Han, Zhijian and Chen, Hao},
title = {Research progress on the antitumor effects of harmine},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1382142}
}
EUVIMED